All Stories

  1. The novel small-molecule antagonist MMG-11 preferentially inhibits TLR2/1 signaling
  2. Lysosomotropic beta blockers induce oxidative stress and IL23A production in Langerhans cells
  3. Identification and characterization of a novel chemotype for human TLR8 inhibitors
  4. LPS-neutralizing peptides reduce outer membrane vesicle-induced inflammatory responses
  5. Intracellular Lipopolysaccharide Sensing as a Potential Therapeutic Target for Sepsis
  6. Synthetic Anti-lipopolysaccharide Peptides (SALPs) as Effective Inhibitors of Pathogen-Associated Molecular Patterns (PAMPs)
  7. Identification of a pyrogallol derivative as a potent and selective human TLR2 antagonist by structure-based virtual screening
  8. Inhibition of Lipopolysaccharide- and Lipoprotein-Induced Inflammation by Antitoxin Peptide Pep19-2.5
  9. Antimicrobial endotoxin-neutralizing peptides promote keratinocyte migration via P2X7 receptor activation and accelerate wound healing in vivo
  10. Antimicrobial Peptides and Their Therapeutic Potential for Bacterial Skin Infections and Wounds
  11. Characterization of reconstructed human skin containing Langerhans cells to monitor molecular events in skin sensitization
  12. Glucocorticoids and Toll-like receptor 2 cooperatively induce acute-phase serum amyloid A
  13. Synthetic anti-endotoxin peptides inhibit cytoplasmic LPS-mediated responses
  14. Cell type-specific regulatory effects of glucocorticoids on cutaneous TLR2 expression and signalling
  15. Biotransformation of 2,4-toluenediamine in human skin and reconstructed tissues
  16. Recognition of Propionibacterium acnes by human TLR2 heterodimers
  17. Synthetic antimicrobial and LPS-neutralising peptides suppress inflammatory and immune responses in skin cells and promote keratinocyte migration
  18. Sphingosine 1-phospate differentially modulates maturation and function of human Langerhans-like cells
  19. Acute myeloid leukaemia-derived Langerhans-like cells enhance Th1 polarization upon TLR2 engagement
  20. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
  21. IL-4 abrogates T H 17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells
  22. Inflammatory conditions distinctively alter immunological functions of Langerhans-like cells and dendritic cellsin vitro
  23. Regulation of Dendritic Cell Function in Inflammation
  24. Chloroquine Promotes IL-17 Production by CD4+T Cells via p38-Dependent IL-23 Release by Monocyte-Derived Langerhans-like Cells
  25. Impact of structural differences in hyperbranched polyglycerol–polyethylene glycol nanoparticles on dermal drug delivery and biocompatibility
  26. Core-multishell nanotransporters enhance skin penetration of the cell-penetrating peptide low molecular weight protamine
  27. Cationic membrane-active peptides - anticancer and antifungal activity as well as penetration into human skin
  28. TLR2/1 and sphingosine 1-phosphate modulate inflammation, myofibroblast differentiation and cell migration in fibroblasts
  29. Increased cutaneous absorption reflects impaired barrier function of reconstructed skin models mimicking keratinisation disorders
  30. Improving Topical Non-Melanoma Skin Cancer Treatment: In vitro Efficacy of a Novel Guanosine-Analog Phosphonate
  31. 9 Mucosal Immunology in Candida albicans Infection
  32. Esterase activity in excised and reconstructed human skin – Biotransformation of prednicarbate and the model dye fluorescein diacetate
  33. Glycosylation of Candida albicans Cell Wall Proteins Is Critical for Induction of Innate Immune Responses and Apoptosis of Epithelial Cells
  34. Host Defence Against Candida albicans and the Role of Pattern-recognition Receptors
  35. Interaction of the mucosal barrier with accessory immune cells during fungal infection
  36. 3D-Wound healing model: Influence of morphine and solid lipid nanoparticles
  37. The Candida albicans cell wall protein Rhd3/Pga29 is abundant in the yeast form and contributes to virulence
  38. Epithelial Cells and Innate Antifungal Defense
  39. Susceptibility testing of amorolfine, bifonazole and ciclopiroxolamine againstTrichophyton rubrumin anin vitromodel of dermatophyte nail infection
  40. Influences of opioids and nanoparticles on in vitro wound healing models
  41. Models of Oral and Vaginal Candidiasis Based on In Vitro Reconstituted Human Epithelia for the Study of Host-Pathogen Interactions
  42. Introduction: Host Responses
  43. Susceptibility testing of amorolfine, bifonazole and ciclopiroxolamine against Trichophyton rubrum in an in vitro model of dermatophyte nail infection
  44. Charakterisierung der Interaktion zwischen Candida albicans und Wirtszellen
  45. Quantitative expression of the Candida albicans secreted aspartyl proteinase gene family in human oral and vaginal candidiasis
  46. Human epithelial cells establish direct antifungal defense through TLR4-mediated signaling
  47. Crosstalk between Keratinocytes and Adaptive Immune Cells in an IκBα Protein-Mediated Inflammatory Disease of the Skin
  48. The Early Transcriptional Response of Human Granulocytes to Infection with Candida albicans Is Not Essential for Killing but Reflects Cellular Communications
  49. Models of oral and vaginal candidiasis based on in vitro reconstituted human epithelia
  50. Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety
  51. In vivo Porphyrin Production by P. acnes in Untreated Acne Patients and its Modulation by Acne Treatment
  52. Receptor-Selective Retinoids for Psoriasis
  53. Stroma-Mediated Dysregulation of Myelopoiesis in Mice Lacking IκBα
  54. Peroxisome Proliferator-Activated Receptors and their Ligands
  55. Induction of Nuclear Factor–κB and c‐Jun/Activator Protein–1 via Toll‐Like Receptor 2 in Macrophages by Antimycotic‐TreatedCandida albicans
  56. Hyaluronic Acid in the Treatment and Prevention of Skin Diseases: Molecular Biological, Pharmaceutical and Clinical Aspects
  57. Toll-like receptors as key mediators in innate antifungal immunity